"Receptors, Opioid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known.
| Descriptor ID |
D011957
|
| MeSH Number(s) |
D12.776.543.750.695.620 D12.776.543.750.720.600.610 D12.776.543.750.750.555.610
|
| Concept/Terms |
Receptors, Opioid- Receptors, Opioid
- Opiate Receptors
- Opioid Receptor
- Receptor, Opioid
- Opioid Receptors
- Opiate Receptor
- Receptor, Opiate
- Receptors, Opiate
Enkephalin Receptor- Enkephalin Receptor
- Receptor, Enkephalin
- Receptors, Enkephalin
- Enkephalin Receptors
beta-Endorphin Receptor- beta-Endorphin Receptor
- Receptor, beta-Endorphin
- beta Endorphin Receptor
- Receptors, beta-Endorphin
- Receptors, beta Endorphin
- beta-Endorphin Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Opioid".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Opioid [D12.776.543.750.695.620]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Neuropeptide [D12.776.543.750.720.600]
- Receptors, Opioid [D12.776.543.750.720.600.610]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Neuropeptide [D12.776.543.750.750.555]
- Receptors, Opioid [D12.776.543.750.750.555.610]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Opioid".
This graph shows the total number of publications written about "Receptors, Opioid" by people in this website by year, and whether "Receptors, Opioid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 0 | 3 | 3 |
| 2018 | 2 | 1 | 3 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Opioid" by people in Profiles.
-
Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx. Mol Cell Proteomics. 2021; 20:100134.
-
Multiple potential targets of opioids in the treatment of acute respiratory distress syndrome from COVID-19. J Cell Mol Med. 2021 01; 25(1):591-595.
-
Treating opioid-induced constipation in patients taking other medications: Avoiding CYP450 drug interactions. J Clin Pharm Ther. 2019 Jun; 44(3):361-371.
-
Blocking drug activation as a therapeutic strategy to attenuate acute toxicity and physiological effects of heroin. Sci Rep. 2018 11 13; 8(1):16762.
-
Curcumin downregulates expression of opioid-related nociceptin receptor gene (OPRL1) in isolated neuroglia cells. Phytomedicine. 2018 Nov 15; 50:285-299.
-
Innovative Opioid Peptides and Biased Agonism: Novel Avenues for More Effective and Safer Analgesics to Treat Chronic Pain. Curr Med Chem. 2018; 25(32):3895-3916.
-
Nociceptin/orphanin FQ antagonizes lipopolysaccharide-stimulated proliferation, migration and inflammatory signaling in human glioblastoma U87 cells. Biochem Pharmacol. 2017 09 15; 140:89-104.
-
An Approach to Spatiotemporally Resolve Protein Interaction Networks in Living Cells. Cell. 2017 04 06; 169(2):350-360.e12.
-
Bifunctional peptide-based opioid agonist/nociceptin antagonist ligand for dual treatment of nociceptive and neuropathic pain. Pain. 2017 03; 158(3):505-515.
-
Novel molecular targets of dezocine and their clinical implications. Anesthesiology. 2014 Mar; 120(3):714-23.